Microplastics Formally Enter EPA’s Regulatory Radar

Microplastics–tiny plastic particles shed from consumer products and waste–have become ubiquitous in our environment, turning up in oceans, soil, the air, and even drinking water. Recently, the U.S. Environmental Protection Agency (EPA) took a notable step by including “microplastics” in its draft Contaminant Candidate List 6 (CCL6): a roster of unregulated substances being considered for potential regulation under the Safe Drinking Water Act. This signals regulators’ recognition of the issue’s importance. 

The controversy around microplastics centers on their unclear health impacts. Early studies have reported the detection of microplastics in drinking water and, in some studies, in human tissues, prompting increased scrutiny of potential risks. Scientists are examining whether ingesting or inhaling these particles could cause physical harm or toxic effects (for instance, through chemicals leaching from plastics or inflammation). So far, evidence of direct harm to humans is inconclusive, but the presence of plastics in the human body is enough to prompt precaution. This uncertainty has led public health advocates to call for more research and preventative action, even as industry groups urge careful risk assessment before drawing conclusions. 

EPA’s recent inclusion of microplastics in its draft CCL6 doesn’t immediately regulate the pollutant; rather, it puts them on the EPA’s radar for further evaluation. The EPA uses the CCL to prioritize research and decide which contaminants should have enforceable standards. By including microplastics, the EPA is acknowledging that these particles may pose a risk to drinking water quality and warrant closer scrutiny.

The American Chemistry Council (ACC)–a major industry association representing chemical and plastics manufacturers–has reacted to EPA’s microplastics initiative with a mix of support and caution. The ACC has voiced support for science-based efforts to understand microplastics, including developing uniform monitoring and conducting research on health effects. In principle, industry stakeholders agree that if microplastics may affect health or the environment, it’s important to have good data on them. However, the ACC also flags “existing hurdles” that make premature regulation difficult. Key challenges highlighted by industry experts include the lack of a standard definition of microplastics, no validated testing methods, and the need for more toxicological research. 

While EPA’s CCL6 move focuses on drinking water, microplastics are also surfacing in regulatory conversations about air quality. Researchers have discovered that microplastics are present in the atmosphere–airborne fibers and particles have been found in city dust and even remote regions via wind transport. This raises the question whether microplastics should be regulated as an air pollutant. 

Under the Clean Air Act, EPA could potentially classify certain airborne microplastic particles as a form of particulate pollution (similar to dust or PM2.5). Environmental advocates have begun discussing whether existing air quality regulations should address microplastics, given their pervasive presence in air and unknown health effects if inhaled. However, the idea of regulating microplastics in air also faces formidable challenges including difficultly in detection and monitoring, the health impacts of inhaling microplastics are not well established, and the feasibility of regulating such a ubiquitous substance that comes from myriad diffuse sources–tire wear, clothing fibers released from dryers, degraded litter, etc.

Looking forward, the inclusion of microplastics on EPA’s CCL6 is a pivotal first step in what will likely be a long, careful process to understand and manage these pollutants. The tone of EPA’s proposal is measured: it highlights concern about microplastics in drinking water while frankly acknowledging that more science is needed before any enforceable standards can be set. This balanced approach aligns with the calls from experts and industry to “learn before we regulate.” 

A few takeaways stand out:

• Regulatory Trajectory: Microplastics are now firmly on the EPA’s agenda. Even though formal regulations (like a drinking water limit) may be years away, companies and water utilities should anticipate increased monitoring and research requirements as EPA gathers data. It’s a signal for all stakeholders to start paying attention to microplastic sources and controls.
• Collaboration on Research: There’s broad agreement on the need for more information. Regulators, academia, and industry are likely to collaborate on defining microplastics, developing testing methods, and assessing health effects. The ACC’s engagement suggests industry will participate in funding research and standard-setting efforts, while also ensuring their concerns (feasibility, practicality) are heard.
• Public and Environmental Health Goal: Ultimately, the driver for these actions is protecting public health and the environment. Even if microplastics’ risks aren’t fully quantified yet, the EPA’s proactive stance shows a precautionary principle at work–tackling potential issues early. As new data emerge in the next few years, we can expect the EPA to adjust its approach, potentially moving from the Candidate List to actual regulatory proposals if warranted by science. 

In the meantime, the inclusion of microplastics in CCL6 serves an important signal function. It puts the issue on the map for water providers and regulators at all levels. Many state agencies and international bodies will be watching EPA’s moves; some may even begin their own monitoring programs. This coordinated attention can accelerate the learning process.